Patient preferences for adherence to treatment for osteoarthritis: The MEdication Decisions in Osteoarthritis Study (MEDOS)

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Laba, Tracey Lea ^a,b   Brien, Jo Anne ^a,c,d   Fransen, Marlene ^a   Jan, Stephen ^b,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Discrete choice experiment; Intentional medication adherence; Osteoarthritis

Indexed keywords

CHONDROITIN; GLUCOSAMINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ARTICLE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PATIENT PREFERENCE; PRESCRIPTION; UNSPECIFIED SIDE EFFECT;

ACETAMINOPHEN; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOICE BEHAVIOR; FEMALE; GLUCOSAMINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MANAGEMENT; PAIN MEASUREMENT; PATIENT PARTICIPATION;

EID: 84877046510     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-160     Document Type: Article

References (50)

1. Burden of major musculoskeletal conditions. Woolf AD, Pfleger B, Bull World Health Organ 2003 81 646 656 14710506 (Pubitemid 37254686)
2. Access Economics Pty Ltd, Painful realities: The economic impact of arthritis in Australia in 2007 A Report for Arthritis Australia. 2007 available online at: http://www.deloitteaccesseconomics.com.au/
3. AIHW, Medication use for arthritis and osteoporosis. Arthritis series no. 11. Cat no. PHE 121 Canberra: Australian Institute of Health and Welfare (AIHW) 2010
4. Barriers to the effectiveness of any intervention in OA. Carr A, Best Pract Res Clin Rheumatol 2001 15 645 656 10.1053/berh.2001.0179 11567545 (Pubitemid 33026126)
5. American College of Rheumatology 2012 Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, Arthritis Care Res 2012 64 465 474
6. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. Wegman A, van der Windt D, van Tulder M, Stalman W, de Vries T, J Rheumatol 2004 31 344 354 14760807 (Pubitemid 38160758)
7. Impact of osteoarthritis and analgesic treatment on quality of life of an elderly population. Briggs A, Scott E, Steele K, Ann Pharmacother 1999 33 1154 1159 10.1345/aph.18411 10573311
8. The escalating cost and prevalence of alternative medicine. MacLennan AH, Wilson DH, Taylor AW, Prev Med 2002 35 166 173 10.1006/pmed.2002.1057 12200102
9. Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older. Sibbritt D, Adams J, Lui CW, Broom A, Wardle J, PLoS One 2012 7 41540 10.1371/journal.pone.0041540 22859995
10. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Black C, Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, Royle P, Thomas S, Health Technol Assess 2009 13 1 148 19846022
11. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Bruyere O, Reginster JY, Drugs & aging 2007 24 573 580 10.2165/00002512-200724070-00005 23682256 (Pubitemid 47195676)
12. About the PBS. http://www.pbs.gov.au/info/about-the-pbs
13. Patterns of analgesic use, pain and self-efficacy: a cross-sectional study of patients attending a hospital rheumatology clinic. Blamey R, Jolly K, Greenfield S, Jobanputra P, BMC Musculoskelet Disord 2009 10 137 10.1186/1471-2474-10-137 19903350
14. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis. Cryer B, Luo X, Assaf AR, Sands G, Mardekian J, Curr Med Res Opin 2011 27 295 302 10.1185/03007995.2010.542056 21142617
15. Racial and ethnic differences in osteoarthritis: prevalence, outcomes, and medical care. Dominick KL, Baker TA, Ethn Dis 2004 14 558 566 15724776 (Pubitemid 39445577)
16. Use of an electronic monitoring aid to investigate the medication pattern of analgesics and non-steroidal anti-inflammatory drugs prescribed for osteoarthritis. Punchak S, Goodyer LI, Miskelly F, Rheumatology (Oxford) 2000 39 448 449 10.1093/rheumatology/39.4.448 (Pubitemid 30307338)
17. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, Urquhart J, van der Linden S, J Rheumatol 2003 30 44 54 12508389 (Pubitemid 36077771)
18. The complexity of the treatment: the decision-making process among women with rheumatoid arthritis. Salt E, Peden A, Qual Health Res 2011 21 214 222 10.1177/1049732310381086 20798264
19. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Lehane E, McCarthy G, Int J Nurs Stud 2007 44 1468 1477 10.1016/j.ijnurstu.2006.07.010 16973166
20. How "bad" does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. Sale JE, Gignac M, Hawker G, Arthritis Rheum 2006 55 272 278 10.1002/art.21853 16583418
21. "It looks after me": how older patients make decisions about analgesics for osteoarthritis. Milder TY, Lipworth WL, Williams KM, Ritchie JE, Day RO, Arthritis Care Res (Hoboken) 2011 63 1280 1286 10.1002/acr.20514
22. Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of risk. Milder TY, Williams KM, Ritchie JE, Lipworth WL, Day RO, Age Ageing 2011 40 254 259 10.1093/ageing/afq160 21187281
23. Patients' preferences for characteristics associated with treatments for osteoarthritis. Ratcliffe J, Buxton M, McGarry T, Sheldon R, Chancellor J, Rheumatology (Oxford) 2004 43 337 345 (Pubitemid 38313184)
24. Treatment options in knee osteoarthritis: the patient's perspective. Fraenkel L, Bogardus ST Jr, Concato J, Wittink DR, Arch Intern Med 2004 164 1299 1304 10.1001/archinte.164.12.1299 15226163 (Pubitemid 38828880)
25. Informed choice and the widespread use of antiinflammatory drugs. Fraenkel L, Wittink DR, Concato J, Fried T, Arthritis Rheum 2004 51 210 214 10.1002/art.20247 15077261 (Pubitemid 38468703)
26. Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect? Fraenkel L, Wittink DR, Concato J, Fried T, J Rheumatol 2004 31 591 593 14994409 (Pubitemid 38337623)
27. Pain relief in osteoarthritis: patients' willingness to risk medication-induced gastrointestinal, cardiovascular, and cerebrovascular complications. Richardson CG, Chalmers A, Llewellyn-Thomas HA, Klinkhoff A, Carswell A, Kopec JA, J Rheumatol 2007 34 1569 1575 17552039 (Pubitemid 47067997)
28. A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis. Hauber AB, Arden NK, Mohamed AF, Reed Johnson F, Peloso PM, Watson DJ, Mavros P, Gammaitoni A, Sen SS, Taylor SD, Osteoarthritis Cartilage 2013 21 2 289 297 10.1016/j.joca.2012.11.007 23182815
29. Therapeutic non-adherence: a rational behavior revealing patient preferences? Lamiraud K, Geoffard P-Y, Health Econ 2007 16 1185 1204 10.1002/hec.1214 17304501 (Pubitemid 350065186)
30. Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia. Laba TL, Brien JA, Jan S, BMC Fam Pract 2012 13 61 10.1186/1471-2296-13-61 22715853
31. Conjoint analysis applications in health-a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J, Value Health 2011 14 403 413 10.1016/j.jval.2010.11.013 21669364
32. Conducting discrete choice experiments to inform healthcare decision making: a user's guide. Lancsar E, Louviere J, Pharmacoeconomics 2008 26 661 677 10.2165/00019053-200826080-00004 18620460 (Pubitemid 351989058)
33. Choice experiments in health: the good, the bad, the ugly and toward a brighter future. Louviere JJ, Lancsar E, Health Econ Policy Law 2009 4 527 546 10.1017/S1744133109990193 19715635
34. A role for conjoint analysis in technology assessment in health care? Ryan M, Int J Technol Assess Health Care 1999 15 443 457 10874373 (Pubitemid 29466178)
35. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Ryan M, Gerard K, Appl Health Econ Health Policy 2003 2 55 64 14619274
36. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Piette JD, Heisler M, Krein S, Kerr EA, Arch Intern Med 2005 165 1749 1755 10.1001/archinte.165.15.1749 16087823 (Pubitemid 41138963)
37. The Primary Care Assessment Survey: tests of data quality and measurement performance. Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE, Med Care 1998 36 728 739 10.1097/00005650-199805000-00012 9596063 (Pubitemid 128456428)
38. Henscher DA, Rose JM, Greene WH, Applied Choice Analysis: A Primer UK: Cambridge University Press 2005
39. Louviere J, Henscher DA, Swait J, Stated choice methods: analysis and application Cambridge: Cambridge University Press 2000
40. Ngene 1.0. http://www.choice-metrics.com/
41. Microsoft Corporation, Microsoft Office Excel 2003 Microsoft Office Professional Editions. 2003
42. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. Buckland-Wright JC, Wolfe F, Ward RJ, Flowers N, Hayne C, J Rheumatol 1999 26 2664 2674 10606380
43. A comparison of approaches to estimating confidence intervals for willingness to pay measures. Hole AR, Health Econ 2007 16 827 840 10.1002/hec.1197 17238222 (Pubitemid 47215133)
44. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Hall J, Kenny P, King M, Louviere J, Viney R, Yeoh A, Health Econ 2002 11 457 465 10.1002/hec.694 12112494 (Pubitemid 34752616)
45. Forest plots in excel software(Data sheet). Available at Please amend to http://www.evidencias.com.br
46. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Lancsar EJ, Hall JP, King M, Kenny P, Louviere JJ, Fiebig DG, Hossain I, Thien FC, Reddel HK, Jenkins CR, Respirology (Carlton, Vic) 2007 12 127 136 10.1111/j.1440-1843.2006.01005.x (Pubitemid 44968212)
47. Therapeutics Goods Administration, Lumaracoxib (Prexige): Medicine recall 2007 Available at http://www.tga.gov.au/safety/recalls-medicine-lumiracoxib- 070810.htm
48. Therapeutic Goods Administration, Vioxx (Rofecoxib): Medicine Recall 2004 Available at http://www.tga.gov.au/safety/recalls-medicine-vioxx-041001.htm
49. Adherence to medication [see comment]. Osterberg L, Blaschke T, N Engl J Med 2005 353 487 497 10.1056/NEJMra050100 16079372 (Pubitemid 41127293)
50. Modelling non-demanders in choice experiments. Ryan M, Skatun D, Health Econ 2004 13 397 402 10.1002/hec.821 15067675 (Pubitemid 38477081)